Precision BioSciences (DTIL) insider buying

Healthcare · Biotechnology · Market cap $151M

9 open-market purchases of DTIL by Precision BioSciences's executives and directors since June 2025, worth $90,443 in total, from SEC Form 4 filings.

The most recent: Stanley Frankel, Director bought $6,000 on September 28, 2026.

The biggest buyer over the period is Stanley Frankel (Director): 3 purchases, $32,109.

By year

YearPurchasesValue
20263$29,501
20256$60,942

Biggest buyers

InsiderBuysValue
Stanley Frankel
Director		3$32,109
Geno J Germano
Director		2$30,545
Melinda Brown
Director		4$27,790

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Sep 28, 2026 Stanley Frankel
Director		 1,000$6.00$6,000 Form 4
Sep 25, 2026 Geno J Germano
Director		 2,609$6.28$16,385 Form 4
Sep 25, 2026 Melinda Brown
Director		 1,135$6.27$7,116 Form 4
Dec 16, 2025 Geno J Germano
 3,000$4.72$14,160 Form 4
Dec 16, 2025 Stanley Frankel
 2,700$4.70$12,690 Form 4
Dec 15, 2025 Melinda Brown
 1,381$4.97$6,864 Form 4
Sep 26, 2025 Stanley Frankel
 2,700$4.97$13,419 Form 4
Sep 22, 2025 Melinda Brown
 1,400$4.89$6,846 Form 4
Jun 25, 2025 Melinda Brown
 1,682$4.14$6,963 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for DTIL.
Open DTIL in Investingly

Questions

Are Precision BioSciences insiders buying the stock?

9 open-market purchases of DTIL by Precision BioSciences's executives and directors since June 2025, worth $90,443 in total, from SEC Form 4 filings. The most recent: Stanley Frankel, Director bought $6,000 on September 28, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Precision BioSciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.